Cannabis Sativa

Cannabis sativa is a tall, slender annual dioecious (occasionally monoecious) flowering plant native to Eastern and Central Asia. It has been cultivated for millennia for its fibre (hemp), edible seeds, and medicinal and psychoactive resin (hashish, marijuana). Sativa-dominant varieties are traditionally associated with uplifting, cerebral, and energising effects, and tend to be higher in tetrahydrocannabinol (THC) relative to cannabidiol (CBD). Modern taxonomy recognises C. sativa as the most widely cultivated and studied of the Cannabis species complex.

Cannabis sativa plants are typically tall (1–5 m) with narrow, serrated, light-green leaflets (often 7–9 per leaf). The stems are robust and fibrous, especially in industrial hemp cultivars. Female plants produce dense clusters of glandular trichomes on the flowers (buds) and surrounding bracts; these trichomes secrete the resin rich in cannabinoids and terpenes. Male plants are generally taller and less bushy, producing pollen-bearing flowers. Root systems are taproot-based and can extend deeply in well-drained soils.

Cannabis sativa has a documented ethnobotanical history spanning over 5,000 years. In traditional Chinese medicine, it was used for pain, rheumatism, and as an anaesthetic (described by Hua Tuo, c. 140–208 CE). In Ayurveda, it was used (as 'bhang' or 'vijaya') for anxiety, insomnia, appetite stimulation, and digestive disorders. In the Middle East and North Africa, hashish was used medicinally and in spiritual/Sufi contexts. Indigenous cultures of the Indian subcontinent and Africa used it for fever, dysentery, and as a mood-enhancer in religious rites.

Cannabis sativa produces over 540 identified phytochemicals. The dominant cannabinoids in sativa-dominant drug-type varieties are tetrahydrocannabinol (THC), typically in the range of 15–25% by dry weight in modern cultivars, with lower CBD levels. Key terpenes include limonene (citrus, uplifting), pinene (pine, memory-retentive), and terpinolene (fresh, herbal). Hemp-type sativa varieties contain less than 0.2–0.3% THC and are bred for CBD, fibre, or seed content. Other notable compounds include cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), and flavonoids such as cannflavin A and B.

Cannabinoids act primarily on the endocannabinoid system. THC is a partial agonist at CB1 (CNS) and CB2 (immune) receptors, producing psychoactive, analgesic, antiemetic, and appetite-stimulating effects. CBD has low affinity for CB receptors but acts as a negative allosteric modulator of CB1, an inhibitor of FAAH (increasing anandamide levels), and modulates 5-HT1A, TRPV1, and PPARγ. Terpenes contribute via entourage effects—limonene has anxiolytic and mood-elevating properties, pinene is a bronchodilator and acetylcholinesterase inhibitor, and beta-caryophyllene is a dietary CB2 agonist.

Dosage varies widely by route and indication. Inhaled THC for analgesia: 1–5 mg per session. Oral THC: 2.5–10 mg per dose, titrated upward. CBD: 300–600 mg/day for anxiety (clinical studies), 10–25 mg/kg/day for epilepsy (e.g., Epidiolex). Medical guidance is strongly advised.

No notes yet.